CytoSorbents Corporation announced that Health Canada has granted Medical Device Authorization for the importation, sale, and emergency use of CytoSorb in hospitalized COVID-19 patients under Interim Order (IO) ID# 316575 [4]. CytoSorbents will collaborate with ebbtides medical [5], a specialty distributor of medical products throughout Canada, to ensure rapid and widespread availability of the therapy.